Janney Montgomery Scott Upgrades Clovis Oncology (CLVS) to Buy
Tweet
Share
E-mail
Get Alerts CLVS Hot Sheet
Price: $0.08 --0%
Rating Summary:
7 Buy, 7 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 3
Rating Summary:
7 Buy, 7 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 3
Join SI Premium – FREE
Janney Montgomery Scott upgraded Clovis Oncology (NASDAQ: CLVS) from Neutral to Buy.
For an analyst ratings summary and ratings history on Clovis Oncology click here. For more ratings news on Clovis Oncology click here.
Shares of Clovis Oncology closed at $87.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Upgrades Yizumi Holdings (300415:CH) to Buy
- Citi Upgrades Orsted (ORSTED:DC) (DOGEF) to Buy
- Goldman Sachs Upgrades Proya Cosmetics Co Ltd (603605:CH) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
